Skip to content

The effect of expressive writing on anxiety sensitivity and severity of symptoms in patients with irritable bowel syndrome

The effect of expressive writing on anxiety sensitivity and severity of symptoms in patients with irritable bowel syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200831048567N1
Enrollment
72
Registered
2020-10-28
Start date
2019-10-07
Completion date
Unknown
Last updated
2020-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Irritable bowel syndrome. Irritable bowel syndrome

Interventions

Intervention 1: Intervention group: Patients with irritable bowel syndrome who Receive expressive writing from a researcher. Intervention 2: Control group: Patients with irritable bowel syndrome who r

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Having IBS based on a doctor's diagnosis Satisfaction and willingness of patients to participate in the study Having symptoms classified based on the irritable bowel syndrome Severity Index (SI-IBS); in the mild, moderate, or severe scale The diagnosis was made at least 3 months ago Be literate enough to write and complete questionnaires The patient is physically and mentally fit to write Does not suffer from acute mental disorders based on the doctor's diagnosis and registration Does not take anti-anxiety medications for the past 3 months based on the patient's record At the same time, participants do not have other functional or structural gastrointestinal disorders based on the patient's record

Exclusion criteria

Exclusion criteria: Diagnosis of any disease during the study by the treating physician Patient’s dissatisfaction or unwillingness to cooperation or to continue with the study Patients who do not participate in pre-test or post-test evaluations Not writing in the booklet more than 2 times or a total of 4 sessions Hospitalization of the patient due to exacerbation of gastrointestinal symptoms during the study

Design outcomes

Primary

MeasureTime frame
Rate of anxiety sensitivity. Timepoint: Before the intervention and 1 month after the intervention (written emotional expression). Method of measurement: Based on the score of (0-144) Revised Anxiety Sensitivity Index (ASI-R).;Severity of gastrointestinal symptoms. Timepoint: Before the intervention and 1 month after the intervention (written emotional expression). Method of measurement: Obtaining a score between 75-500 Based on Irritable Bowel Syndrome Severity Index (IBS-SI) Questionnaire.

Secondary

MeasureTime frame
Anxiety Sensitivity Score in the Revised Anxiety Sensitivity Index (ASI-R) Questionnaire. Timepoint: Before the intervention and 1 month after the intervention. Method of measurement: Revised Anxiety Sensitivity Index (ASI-R) Questionnaire.;Gastrointestinal symptom severity score in Irritable Bowel Syndrome Severity Index (IBS-SI). Timepoint: Before the intervention and 1 month after the intervention. Method of measurement: Irritable Bowel Syndrome Severity Index (IBS-SI) Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMarzieh Borjian

Iran University of Medical Sciences

M.Borjian@yahoo.com+98 21 8879 4302

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026